RO.CH

300.8

+0.8%↑

NOVN.CH

105.4

+1.27%↑

LONN.CH

549.8

+1.4%↑

SDZ.CH

46.38

+1.49%↑

STMN.CH

88.72

+0.91%↑

RO.CH

300.8

+0.8%↑

NOVN.CH

105.4

+1.27%↑

LONN.CH

549.8

+1.4%↑

SDZ.CH

46.38

+1.49%↑

STMN.CH

88.72

+0.91%↑

RO.CH

300.8

+0.8%↑

NOVN.CH

105.4

+1.27%↑

LONN.CH

549.8

+1.4%↑

SDZ.CH

46.38

+1.49%↑

STMN.CH

88.72

+0.91%↑

RO.CH

300.8

+0.8%↑

NOVN.CH

105.4

+1.27%↑

LONN.CH

549.8

+1.4%↑

SDZ.CH

46.38

+1.49%↑

STMN.CH

88.72

+0.91%↑

RO.CH

300.8

+0.8%↑

NOVN.CH

105.4

+1.27%↑

LONN.CH

549.8

+1.4%↑

SDZ.CH

46.38

+1.49%↑

STMN.CH

88.72

+0.91%↑

Search

Sonova Holding AG

Geschlossen

BrancheGesundheitswesen

219.4 0.27

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

216.3

Max

220.7

Schlüsselkennzahlen

By Trading Economics

Einkommen

443M

Verkäufe

2B

KGV

Branchendurchschnitt

24.42

35.739

EPS

5.55

Dividendenrendite

1.99

Gewinnspanne

21.819

Angestellte

18,335

EBITDA

510M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+12.52% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

1.99%

3.08%

Nächstes Ergebnis

14. Nov. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-4.8B

13B

Vorheriger Eröffnungskurs

219.13

Vorheriger Schlusskurs

219.4

Nachrichtenstimmung

By Acuity

29%

71%

74 / 371 Ranking in Healthcare

Sonova Holding AG Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

25. Sept. 2025, 13:05 UTC

Wichtige Markttreiber

European Med-Tech Stocks Fall After U.S. Opens Import Probe

Peer-Vergleich

Kursveränderung

Sonova Holding AG Prognose

Kursziel

By TipRanks

12.52% Vorteil

12-Monats-Prognose

Durchschnitt 243.5 CHF  12.52%

Hoch 294 CHF

Tief 195 CHF

Basierend auf 8 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Sonova Holding AG – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

8 ratings

2

Buy

3

Halten

3

Sell

Stimmung

By Acuity

74 / 371 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Sonova Holding AG

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved in the design, development, manufacture, distribution, and service of hearing implants and related products under the Advanced Bionics brand. The company sells its products through independent distributors; and provides hearing care services through a network of stores and clinics. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. The company was founded in 1947 and is headquartered in Stäfa, Switzerland.
help-icon Live chat